£795.00

The 2023 Report on Cell-Based Brain Tumor Therapeutics: World Market Segmentation by City

Price data last checked 149 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 8 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 100 days • 100 data points (No recent data available)

Historical
Generating forecast...
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 05 October 2025 29 October 2025 23 November 2025 18 December 2025 12 January 2026

Price Distribution

Price distribution over 100 days • 1 price levels

Days at Price
100 days 0 25 50 75 100 £795 Days at Price

Price Analysis

Most common price: £795 (100 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 100 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
09 June 2022
Listed Since
30 June 2022

Similar Products You Might Like

The 2023 Report on Primary Brain Tumor Diagnosis and Treatments: World Market Segmentation by City
98% match

The 2023 Report on Primary Brain Tumor Diagnosis and Treatments: World Market Segmentation by City

£795.00 04 Feb 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India
98% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in India

£515.00 24 Feb 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in the United States
98% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in the United States

£520.00 11 Jan 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in India
98% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in India

£515.00 10 Dec 2025
The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City
98% match

The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City

£795.00 15 Apr 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in the United States
98% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in the United States

£520.00 10 Jan 2026
The 2021-2026 World Outlook for Circulating Tumor Cell (CTC) Technologies
97% match

The 2021-2026 World Outlook for Circulating Tumor Cell (CTC) Technologies

£795.00 13 Dec 2025
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China
97% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in China

£495.00 11 Jan 2026
The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in Japan
97% match

The 2023-2028 Outlook for Brain Tumor Diagnosis and Treatments in Japan

£495.00 13 Dec 2025
The 2023 Report on Non-Hodgkin Lymphoma Chemotherapy Therapeutics: World Market Segmentation by City
97% match

The 2023 Report on Non-Hodgkin Lymphoma Chemotherapy Therapeutics: World Market Segmentation by City

£795.00 13 Jan 2026
The 2023 Report on Cancer Profiling and Pathways: World Market Segmentation by City
97% match

The 2023 Report on Cancer Profiling and Pathways: World Market Segmentation by City

£795.00 12 Jan 2026
The 2016 Report on Lymphoma Therapeutics: World Market Segmentation by City
97% match

The 2016 Report on Lymphoma Therapeutics: World Market Segmentation by City

£995.00 11 Jan 2026
The 2023 Report on Uterine Cancer Therapeutics and Diagnostics: World Market Segmentation by City
97% match

The 2023 Report on Uterine Cancer Therapeutics and Diagnostics: World Market Segmentation by City

£795.00 07 Jan 2026
The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments
97% match

The 2023-2028 World Outlook for Brain Tumor Diagnosis and Treatments

Out of Stock 06 Jan 2026
The 2025-2030 World Outlook for Brain Tumor Diagnosis and Treatments
97% match

The 2025-2030 World Outlook for Brain Tumor Diagnosis and Treatments

Out of Stock 11 Jan 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
97% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 08 Jan 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China
97% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in China

£495.00 12 Mar 2026
The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan
97% match

The 2023-2028 Outlook for Primary Brain Tumor Diagnosis and Treatments in Japan

£495.00 13 Jan 2026
The 2023 Report on Head and Neck Cancer Diagnostics: World Market Segmentation by City
97% match

The 2023 Report on Head and Neck Cancer Diagnostics: World Market Segmentation by City

£795.00 12 Jan 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 11 Jan 2026
The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City
97% match

The 2016 Report on Liver Cancer Drugs: World Market Segmentation by City

£995.00 06 Jan 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
97% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 14 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
97% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 09 Apr 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 22 Jan 2026